Cargando…

Author Correction: Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1/2 pathway

Detalles Bibliográficos
Autores principales:	Singh, Kanika, Gupta, Ankit, Sarkar, Ashish, Gupta, Ishita, Rana, Santanu, Sarkar, Sagartirtha, Khan, Sameena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314792/ https://www.ncbi.nlm.nih.gov/pubmed/32581244 http://dx.doi.org/10.1038/s41598-020-67556-8

Ejemplares similares

Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1/2 pathway
por: Singh, Kanika, et al.
Publicado: (2020)

Plant arginyltransferases (ATEs)
por: Domitrovic, Tatiana, et al.
Publicado: (2017)

Tomoregulin-1 prevents cardiac hypertrophy after pressure overload in mice by inhibiting TAK1-JNK pathways
por: Bao, Dan, et al.
Publicado: (2015)

Liquiritin Attenuates Angiotensin II-Induced Cardiomyocyte Hypertrophy via ATE1/TAK1-JNK1/2 Pathway
por: Mo, Jiajia, et al.
Publicado: (2022)

GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK/p38 signaling pathway
por: Li, Jia, et al.
Publicado: (2022)

Regulation of Mitochondrial Respiratory Chain Complex Levels, Organization, and Function by Arginyltransferase 1
por: Jiang, Chunhua, et al.
Publicado: (2020)

TAK1 safeguards endothelial cells from gut microbes and inflammation
por: Naito, Hisamichi, et al.
Publicado: (2019)

Author Correction: Farnesoid X receptor activation inhibits TGFBR1/TAK1-mediated vascular inflammation and calcification via miR-135a-5p
por: Li, Chao, et al.
Publicado: (2020)

Paclitaxel induces apoptosis through the TAK1–JNK activation pathway
por: Yu‐Wei, Di, et al.
Publicado: (2020)

RNA helicase DP103 and TAK1: a new connection in cancer
por: Shin, Eun Myoung, et al.
Publicado: (2015)

Functional Interplay between Arginyl-tRNA Synthetases and Arginyltransferase
por: Avcilar-Kucukgoze, Irem, et al.
Publicado: (2022)

Field populations of native Indian honey bees from pesticide intensive agricultural landscape show signs of impaired olfaction
por: Chakrabarti, Priyadarshini, et al.
Publicado: (2015)

TAK1-dependent autophagy: A suppressor of fatty liver disease and hepatic oncogenesis
por: Seki, Ekihiro
Publicado: (2014)

SHP‐1 suppresses endotoxin‐induced uveitis by inhibiting the TAK1/JNK pathway
por: Zhuang, Xiaonan, et al.
Publicado: (2020)

Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis
por: Birnbaum, Michael D., et al.
Publicado: (2018)

Arginyltransferase ATE1 suppresses cell tumorigenic potential and inversely correlates with metastases in human cancers
por: Rai, Reena, et al.
Publicado: (2015)

Posttranslational Arginylation Enzyme Arginyltransferase1 Shows Genetic Interactions With Specific Cellular Pathways in vivo
por: Wiley, David J., et al.
Publicado: (2020)

Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System That Regulate Apoptosis
por: Gupta, Ishita, et al.
Publicado: (2018)

Differential and Conditional Activation of PKC-Isoforms Dictates Cardiac Adaptation during Physiological to Pathological Hypertrophy
por: Naskar, Shaon, et al.
Publicado: (2014)

Author Correction: Strictly regulated agonist-dependent activation of AMPA-R is the key characteristic of TAK-653 for robust synaptic responses and cognitive improvement
por: Suzuki, Atsushi, et al.
Publicado: (2021)

Author Correction: NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?
por: Gupta, Shilpa, et al.
Publicado: (2020)

Arginyltransferase ATE1 is targeted to the neuronal growth cones and regulates neurite outgrowth during brain development
por: Wang, Junling, et al.
Publicado: (2017)

Arginyltransferase (Ate1) regulates the RGS7 protein level and the sensitivity of light-evoked ON-bipolar responses
por: Fina, Marie E., et al.
Publicado: (2021)

Author Correction: Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
por: Deng, Ke-Qiong, et al.
Publicado: (2023)

Ubiquitin Proteasome pathway proteins as potential drug targets in parasite Trypanosoma cruzi
por: Gupta, Ishita, et al.
Publicado: (2018)

Author’s Response
por: Samajdar, Shambo Samrat, et al.
Publicado: (2023)

Dual‐Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1
por: Zhao, Jing, et al.
Publicado: (2021)

Author Correction: PQM-1 controls hypoxic survival via regulation of lipid metabolism
por: Heimbucher, Thomas, et al.
Publicado: (2020)

Authors’ response
por: Gupta, Ritu, et al.
Publicado: (2021)

In Vivo Knockdown of TAK1 Accelerates Bone Marrow Proliferation/Differentiation and Induces Systemic Inflammation
por: Vink, Paul M., et al.
Publicado: (2013)

Author response
por: Sivakumar, Kothandam, et al.
Publicado: (2022)

Knockdown of CPEB1 and CPEB4 Inhibits Scar Formation via Modulation of TAK1 and SMAD Signaling
por: Cui, Hui Song, et al.
Publicado: (2023)

Author Correction: Heart Failure Phenotypes Induced by Knockdown of DAPIT in Zebrafish: A New Insight into Mechanism of Dilated Cardiomyopathy
por: Nagata, Yoji, et al.
Publicado: (2018)

Biochemical characterization of TRIM72 E3 ligase and its interaction with the insulin receptor substrate 1
por: Gupta, Ishita, et al.
Publicado: (2020)

Author Correction: A microRNA program regulates the balance between cardiomyocyte hyperplasia and hypertrophy and stimulates cardiac regeneration
por: Raso, Andrea, et al.
Publicado: (2022)

Author Correction: Efficacy of resistance training in hypoxia on muscle hypertrophy and strength development: a systematic review with meta-analysis
por: Benavente, Cristina, et al.
Publicado: (2023)

Author Correction: Knockdown of mechanosensitive adaptor Hic-5 ameliorates post-traumatic osteoarthritis in rats through repression of MMP-13
por: Miyauchi, Aya, et al.
Publicado: (2023)

Author Correction: Endomucin knockdown inhibits VEGF-induced endothelial cell migration, growth, and morphogenesis by modulating VEGFR2 signaling
por: Park-Windhol, Cindy, et al.
Publicado: (2023)

Authors’ response
por: Mukhopadhyay, Labanya, et al.
Publicado: (2021)

SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1‐Dependent Manner
por: Qian, Qiaofeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_te8tetp682s30130u2l6gj26a0